1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Nanoform Finland Oyj
  6. News
  7. Press Releases
    NANOFH   FI4000330972

NANOFORM FINLAND OYJ

(NANOFH)
  Report
Delayed Nasdaq Helsinki  -  10:33 2022-08-10 am EDT
3.695 EUR    0.00%
04:01aInvitation to Nanoform's Interim Report January-June 2022
AQ
07/14Nanoform and Pharmanovia to breathe new life into iconic medicines
AQ
07/14Nanoform Finland Plc Partners with Pharmanovia for Iconic Medicines
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société NANOFORM FINLAND OYJ
04:01aInvitation to Nanoform's Interim Report January-June 2022
AQ
07/14Nanoform and Pharmanovia to breathe new life into iconic medicines
AQ
06/13Nanoform Chief of Business Operations Gonçalo Andrade steps down
AQ
06/13Nanoform Finland Plc - Manager's transactions - Jeanne Thoma
AQ
06/13Nanoform Finland Plc - Manager's transactions - Albert Hæggström
AQ
06/13Nanoform Finland Plc - Manager's transactions - Mads Laustsen
AQ
06/06Share subscriptions based on Nanoform Finland Plc's stock options 1-2/2019 and 1/2020
AQ
06/06The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key..
AQ
06/06Nanoform Finland Plc - Manager's transactions - Miguel Calado
AQ
06/02NANOFORM FINLAND OYJ : Plc – Manager's transactions – Niklas Sandler
PU
06/02Nanoform Finland Plc - Manager's transactions - Niklas Sandler
AQ
05/30Nanoform Finland Plc - Manager's transactions - Gonçalo Andrade
AQ
05/24NANOFORM 1Q 2022 REPORT : Quarterly record of new projects and new customers
AQ
05/10Invitation to Nanoform's Interim Report January-March 2022
AQ
05/04Nanoform launches "STARMAP Online" placing AI-power at the fingertips of medicine devel..
AQ
04/12Nanoform Finland Plc - Manager's transactions - Niklas Sandler
AQ
04/12Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland P..
AQ
04/12Share subscriptions based on Nanoform Finland Plc's multiple Stock Option Programs
AQ
04/12Resolutions of Nanoform Finland Plc's Annual General Meeting on April 12, 2022
AQ
03/25Nanoform Finland Plc - Manager's transactions - Gonçalo Andrade
AQ
03/24Herantis PharmaAnnounces Successful HER-096 Initial Results with Nanoform Technology
AQ
03/23New shares of Nanoform registered with the trade register
AQ
03/22Nanoform successfully completes new share issue raising EUR 25 million to prepare for G..
AQ
03/22Nanoform announces its intention to carry out a new share issue to raise approximately ..
AQ
03/17Notice to the Annual General Meeting of NANOFORM FINLAND Plc
AQ
03/12NANOFORM FINLAND OYJ : triples its GMP capacity and adds high potent handling (OEL <30 ng/..
PU
02/22NANOFORM 4Q AND FULL YEAR 2021 REPOR : accelerating GMP growth
AQ
02/08Invitation to Nanoform's Q4 and full year 2021 report February 22, 2022
AQ
02/04Nanoform signs GMP manufacturing program with TargTex following formulation success
AQ
01/03Nanoform sets two new near-term business targets for 2022
AQ
2021Nanoform financial calendar for 2022
AQ
2021NANOFORM FINLAND OYJ : Interim Report January – September 2021
PU
2021Nanoform Interim Report January - September 2021
AQ
2021NANOFORM FINLAND OYJ : Interim Report for January-September 2021 – Report
PU
2021Resolutions of Nanoform Finland Plc's Extraordinary General Meeting on November 17, 202..
AQ
2021Nanoform wins Star of Innovation award at the European Small and Mid-Cap Awards 2021
AQ
2021Nanoform signs GMP agreement and achieves near-term business target
AQ
2021NANOFORM RECEIVES ISO/IEC 27001 : 2013 certification for its Information Security Manageme..
AQ
2021Invitation to presentation of Nanoform's Q3/2021 report on November 25, 2021
PU
2021Invitation to presentation of Nanoform's Q3/2021 report on November 25, 2021
AQ
2021NANOFORM FINLAND OYJ : trailblazing progress earns recognition from prestigious industry a..
PU
2021NANOFORM FINLAND OYJ : convenes EGM to elect Jeanne Thoma as board member
AQ
2021NANOFORM FINLAND OYJ : Notice to the Extraordinary General Meeting of NANOFORM FINLAND PLC
AQ
2021NANOFORM FINLAND OYJ : receives funding to solve challenges for global health
AQ
2021NANOFORM FINLAND OYJ : Plc – Manager's transactions – Gonçalo Andrade
PU
2021NANOFORM FINLAND PLC : - Manager's transactions - Gonçalo Andrade
AQ
2021NANOFORM FINLAND OYJ : shortlisted for the European Small and Mid-Cap Awards 2021
AQ
2021NANOFORM FINLAND OYJ : technology delivers successful results for Herantis CDNF drug candi..
AQ
2021HERANTIS PHARMA OYJ : Announces Successful rhCDNF Results With Nanoform Technology
AQ
2021NANOFORM FINLAND OYJ : The Board of Directors of Nanoform Finland Plc decided on issue of ..
AQ
2021NANOFORM FINLAND OYJ : Interim Report for January-June 2021 – Report
PU
2021NANOFORM FINLAND OYJ : Interim Report January – June 2021
PU
2021NANOFORM FINLAND OYJ : Interim Report January - June 2021
AQ
2021NANOFORM FINLAND OYJ : Invitation to presentation of Nanoform's Q2/2021 report on August 2..
PU
2021NANOFORM FINLAND OYJ : Invitation to presentation of Nanoform's Q2/2021 report on August 2..
AQ
2021NANOFORM FINLAND OYJ : and Boehringer Ingelheim execute master services agreement
AQ
2021NANOFORM FINLAND OYJ : Plc – Manager's transactions – Gonçalo Andrade
PU
2021NANOFORM FINLAND PLC : - Manager's transactions - Gonçalo Andrade
AQ
2021NANOFORM FINLAND OYJ : Share subscriptions based on Nanoform Finland Plc's multiple Stock ..
PU
2021NANOFORM FINLAND OYJ : The Board of Directors of Nanoform Finland Plc decided on issue of ..
AQ
2021NANOFORM FINLAND OYJ : Share subscriptions based on Nanoform Finland Plc's multiple Stock ..
AQ
2021NANOFORM FINLAND OYJ : raises its mid-term business targets for 2025
AQ
2021NANOFORM FINLAND OYJ : Interim Report January – March (Q1) 2021
PU
2021NANOFORM FINLAND OYJ : Interim Report January - March (Q1) 2021
AQ
2021NANOFORM FINLAND OYJ : and Celanese Explore Ways to Enhance Drug Delivery
AQ
2021NANOFORM FINLAND OYJ : Cynthia Schwalm transitions to Senior Advisor Business Development ..
AQ
2021NANOFORM FINLAND OYJ : final clinical results confirm value proposition to the pharma indu..
PU
2021NANOFORM FINLAND OYJ : final clinical results confirm value proposition to the pharma indu..
AQ
2021NANOFORM FINLAND OYJ : Invitation to presentation of Nanoform's Q1/2021 report on May 27, ..
PU
2021NANOFORM FINLAND OYJ : Invitation to presentation of Nanoform's Q1/2021 report on May 27, ..
AQ
2021NANOFORM FINLAND OYJ : The Board of Directors of Nanoform Finland Plc decided on issue of ..
AQ
2021NANOFORM FINLAND OYJ : and Aprecia collaborate to advance 3D printed Nanomedicines
AQ
2021NANOFORM FINLAND OYJ : Plc – Manager's transactions – Gonçalo Andrade
PU
2021NANOFORM FINLAND PLC : - Manager's transactions - Gonçalo Andrade
AQ
2021NANOFORM FINLAND OYJ : Share subscriptions based on Nanoform Finland Plc's multiple Stock ..
PU
1  2Next
Upcoming event on NANOFORM FINLAND OYJ